Robert Slinger
Children's Hospital of Eastern Ontario
48 Papers
343 Citations
Robert Slinger is an academic researcher from Children's Hospital of Eastern Ontario. The author has contributed to research in topics: Medicine & Bordetella pertussis. The author has an hindex of 17, co-authored 48 publications. Previous affiliations of Robert Slinger include University of Ottawa.
Chat about Author
Papers
Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms
TL;DR: Honey, which is a natural, nontoxic, and inexpensive product, is effective in killing SA and PA bacterial biofilms, which may have important clinical implications and could lead to a new approach for treating refractory CRS.
255
Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms
TL;DR: Manuka honey (MH) has been shown to be both an effective in vitro treatment agent for SA and PA biofilms and nontoxic to sinonasal respiratory mucosa, and Methylglyoxal (MGO) was reported to be the major antibacterial agent in MH.
93
Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms.
Robert Slinger,Francis K.L. Chan,Wendy Ferris,Sau-Wai Yeung,Melissa St. Denis,Isabelle Gaboury,Shawn D. Aaron +6 more
TL;DR: Biofilm testing reveals differences in effectiveness among antibiotics not apparent from conventional susceptibility testing, and suggests novel antibiotic regimens that could be studied for treatment of OME.
87
Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.
TL;DR: Although it failed to show non-inferiority of duration of sepsis in the cloxacillin and gentamicin group compared to the vancomycin and genticin group, duration ofSepsis was clinically similar, and Restricting vancomYcin for confirmed cases of CONS sepsi resistant to oxacillin appears effective and safe, and significantly reduces vancomys use in the NICU.
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series
Robert Slinger,Marc Desjardins,Anne E. McCarthy,Karam Ramotar,Peter Jessamine,Christiane Guibord,Baldwin Toye +6 more
TL;DR: The authors' cases provide further evidence that reduced fluoroquinolone susceptibility of S. Typhi and S. Paratyphi is clinically significant and Laboratories should test extra-intestinal Salmonella spp.